APOBEC3B mutagenesis in cancer
暂无分享,去创建一个
[1] Steven A. Roberts,et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.
[2] N. A. Temiz,et al. Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.
[3] M. Stratton,et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis , 2013, eLife.
[4] Jason B. Nikas,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[5] M. Nussenzweig,et al. Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. , 2013, Annual review of pathology.
[6] I. Rogozin,et al. AID/APOBEC cytosine deaminase induces genome-wide kataegis , 2012, Biology Direct.
[7] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[8] L. Loeb,et al. The mutator phenotype in cancer: molecular mechanisms and targeting strategies. , 2010, Current drug targets.
[9] Takeshi Azuma,et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium , 2007, Nature Medicine.
[10] Reuben S. Harris,et al. Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.
[11] M. Malim,et al. Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.
[12] Reuben S Harris,et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. , 2004, Journal of molecular biology.
[13] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] Trevor J Pugh,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[15] L. Loeb,et al. Mutagenesis by apurinic/apyrimidinic sites. , 1986, Annual review of genetics.